Yorsua, Mivel .
HRN: 25-74-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2024
CEFUROXIME 500MG (TAB)
08/23/2024
08/29/2024
PO
500mg
BID
Post Cs
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes